[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.120.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
October 18, 2006

High-Dose Statins and Atherosclerosis Regression

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2006;296(15):1836-1837. doi:10.1001/jama.296.15.1837-a

To the Editor: Dr Nissen and colleagues1 reported coronary plaque regression as a result of high-dose statin therapy. In their “Comment” section, Figure 3 illustrates the relationship between achieved LDL-C levels and changes in plaque size using intravascular ultrasound, based on data from 3 randomized pharmacological intervention trials. It appears that an LDL-C value of 76 mg/dL was the cutoff at which the linear regression analysis predicted no plaque increase: the transition from progression to regression.

First Page Preview View Large
First page PDF preview
First page PDF preview
×